Immune response visualized in vivo by [18F]-FDG PET/CT after COVID-19 vaccine

13Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

Abstract

Worldwide deployment of COVID-19 vaccines is in progress. Recent immune activation following vaccination can sometimes be seen in fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography ([18F]-FDG PET/CT). As previously evidenced, FDG-avid axillary lymph node(s) are common in patients receiving vaccines against SARS-CoV-2, influenza virus, or human papillomavirus, and reflect a regional immune response. In addition, these findings may also be accompanied by an increased spleen glucose metabolism after the COVID-19 vaccine, which captures a systemic immune response. Hence, we provide here a clinical example demonstrating that immune response could be associated with increased glucose metabolism in lymphoid organs such as lymph nodes and the spleen, which are critical modulators of T cell immunity. We believe that it is of paramount importance that nuclear physicians should be able to recognize clinical and imaging features of such immune responses upon vaccination for COVID-19 and beyond.

Cite

CITATION STYLE

APA

Seban, R. D., Champion, L., Deleval, N., Richard, C., & Provost, C. (2021). Immune response visualized in vivo by [18F]-FDG PET/CT after COVID-19 vaccine. Diagnostics, 11(4). https://doi.org/10.3390/diagnostics11040676

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free